Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics
暂无分享,去创建一个
Xiang Yang Zhang | Thomas R. Kosten | T. Kosten | M. Xiu | X. Zhang | D. C. Chen | L. Hui | Y. Dang | T. Hou | C. Zhang | You Lan Zheng | Mei Hong Xiu | Li Hui | Yu Feng Dang | Tian De Hou | Chong Xi Zhang | Da Chun Chen | D. Chen | Y. Zheng
[1] Alexander L. Miller,et al. First-Episode Psychosis: A Window of Opportunity for Best Practices , 2007, CNS Spectrums.
[2] Y. Loh,et al. A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons , 2008, Molecular and Cellular Neuroscience.
[3] F. Taneli,et al. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[4] K. Hashimoto,et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls , 2003, Neuroscience Letters.
[5] F. Angelucci,et al. Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions. , 2000, The international journal of neuropsychopharmacology.
[6] H. Danker-Hopfe,et al. Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse , 2004, Neuroscience Letters.
[7] D. Souza,et al. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. , 2007, Journal of psychiatric research.
[8] J. Thome,et al. Neurotrophic factors and the pathophysiology of schizophrenic psychoses , 2004, European Psychiatry.
[9] Chien-Te Lee,et al. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. , 2006, Journal of psychiatric research.
[10] F. Mosquera,et al. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients , 2006, Schizophrenia Research.
[11] Abraham Weizman,et al. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia , 2005, European Neuropsychopharmacology.
[12] Kenji Hashimoto,et al. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[13] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[14] M. Berk,et al. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder , 2007, Neuroscience Letters.
[15] S. Radka,et al. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay , 1996, Brain Research.
[16] Zin Z. Khaing,et al. BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs , 2001, The European journal of neuroscience.
[17] M. Schwald,et al. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.
[18] H. Nawa,et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients , 2002, Psychiatry Research.
[19] H. Qing,et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus , 2002, Neuroscience Letters.
[20] K. Nylen,et al. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration , 2002, Brain Research.
[21] T. Kosten,et al. BDNF Levels and Genotype are Associated with Antipsychotic-Induced Weight Gain in Patients with Chronic Schizophrenia , 2008, Neuropsychopharmacology.
[22] J. Virchow,et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma , 2004, Neurobiology of Aging.
[23] H Nawa,et al. Cytokine and growth factor involvement in schizophrenia—support for the developmental model , 2000, Molecular Psychiatry.
[24] J. Kleinman,et al. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia , 2003, Molecular Psychiatry.
[25] A. Teixeira,et al. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia , 2008, Neuroscience Letters.
[26] A. Genazzani,et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. , 2007, Human reproduction.
[27] R. Yoshimura,et al. Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment , 2007, Neuropsychiatric disease and treatment.
[28] A. Terry,et al. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus , 2006, Schizophrenia Research.
[29] X. Zhang,et al. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics , 2005, Neuroscience Letters.
[30] Yan Shen,et al. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. , 2007, Journal of psychiatric research.
[31] D. Keegan,et al. Expression of brain‐derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs , 2003, Journal of neuroscience research.
[32] N. Yahata,et al. Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia , 2008, Schizophrenia Research.
[33] William A Banks,et al. Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.
[34] A. Kastania,et al. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.